Black Diamond Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BDTX and other ETFs, options, and stocks.

About BDTX

Black Diamond Therapeutics, Inc. is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. The company’s MasterKey therapies are designed to address a broad spectrum of genetically defined tumors, overcome resistance, minimize wild-type-mediated toxicities, and be brain-penetrant to treat central nervous system diseases.

CEO

Mark A. Velleca

CEOMark A. Velleca

Employees

Employees24

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

2014

Founded2014

Employees

Employees24

BDTX Key Statistics

Market cap

103.58M

Market cap103.58M

Price-Earnings ratio

30.63

Price-Earnings ratio30.63

Dividend yield

—

Dividend yield—

Average volume

1.44M

Average volume1.44M

High today

$1.84

High today$1.84

Low today

$1.79

Low today$1.79

Open price

$1.84

Open price$1.84

Volume

132.82K

Volume132.82K

52 Week high

$6.75

52 Week high$6.75

52 Week low

$1.20

52 Week low$1.20

People also own

Based on the portfolios of people who own BDTX. This list is generated using Robinhood data, and it’s not a recommendation.